Evaluation of Influence of Archachatina marginata Mucin on the Body Weight and Some Gastric Secretions of Wistar Rats Induced with Gastric Ulcer

Main Article Content

Rizwan, A. Ansari
Karimah, Mohammad Rabiu
Oludunni Otanwa Omolabake
Elendu Melford Uche


The aim of this study was to evaluate the influence of A. marginata mucin on the gastric secretions and body weight of wistar rats induced with gastric ulcer. Thirty (30) adult male wistar rats were divided into six groups of five rats each. Group I (normal control) was administered with 2ml/kg distilled water, while Groups II III, IV and V were induced with ulceration via oral administration of 120mg/kg indomethacin. After ulceration had been confirmed successfully induced, while Group II was left untreated with mucin, III, IV and V were treated with 200mg/kg, 400mg/kg and 800mgl/kg mucin respectively. Meanwhile, Group VI was administered with 20mg/kg omeprazole (standard drug). Body weight of rats was determined after induction (initial) and after treatment (final).  The values recorded for free acidity (FA), total acidity (TA), pepsin activity (PA) and acid output (AO) for the untreated ulcer rats (Group II) were significantly high (63.20±7.66mEq/L), (91.40±6.34mEq/L), (1.63±0.09μEq/L/4hr) and (0.43±0.04μg/ml) respectively. However, significant reduction in the aforementioned parameters was established with mucin treatment in a dose dependent manner, such that Group V administered with 800mg/kg manifested the lowest level of FA (47.40±7.19 mEq/L), TA (72.00±6.36), PA (1.39±0.07 μg/ml) and AO (0.16±0.05 μg/ml) which was not significantly different from the values recorded for Group VI treated with the standard drug (omeprazole).The values recorded on the body weight of Group II reduced with the induction of gastric ulcer. However, a dose dependent increase was observed in all treated groups. In conclusion, through this study, it has been established that A. marginata mucin could be explored for the development of anti-ulcer therapy.

Mucin, Archachatina marginata, omeprazole and indomethacin.

Article Details

How to Cite
Ansari, R. A., Rabiu, K. M., Omolabake, O. O., & Uche, E. M. (2020). Evaluation of Influence of Archachatina marginata Mucin on the Body Weight and Some Gastric Secretions of Wistar Rats Induced with Gastric Ulcer. Asian Journal of Biochemistry, Genetics and Molecular Biology, 5(2), 31-36. https://doi.org/10.9734/ajbgmb/2020/v5i230128
Original Research Article


Harathi Y, Jerzy S. Protective Factors of the Gastric and Duodenal Mucosa: An Overview. Current Gastroenterology Reports. 2015;17:24.

Rod D, Andrea V. Attack and defence in the gastric epithelium – a delicate balance. Experimental Physiology. 2007;92(4): 591–601.

Peckenpaugh NJ, Poleman CM. Nutrition Essentials and Diet therapy. Philadelphia, PA: WB Sauder Company. 1997;32-36.

Moss SF, Sood S. Helicobacter pylori Current Opinion in Infectious Diseases. 2003;16(5):445-51.

Gerken TA. Biophysical approaches to salivary mucin structural conformation and dynamics. Critical Reviews in Oral Biology and Medicine. 1993;4(3):261.

Adikwu MU, Ikejiuba CC. Some physicochemical and wound healing properties of snail mucin. Bollettino Chimico Farmaceutico. 2005;145(2):5.

Lorke D. New approach to practical acutetoxicity. Archives of Toxicology. 1983; 6(13):54.

Kikuko A, Shnichi K, Hiroshi Y, Sugumu O. Effect of novel H2 receptor antagonist on gastric secretions and gastroduodenal ulcers in rats. Arzenem-Forsch/drug Research. 1996;46(1):177-185.

Kulkarni SK. Experiments on intact preparations (invivo studies). Handbook of Experimental Pharmacology. Delhi: Vallabh Prakashan. 2005;148.

Ishizuka Y, Kamisaki T, Okomoto N, Matsuda M, Shimazaki I, Kimura I, Kamaya I, Kataoka M, Kawashima M, Terashima K, Sato M. Effect of 1, 6 dihydro-2-(2- methylpropoxy)aniline-6-oxo-5-pyridinecarboxylic acid on gastric secretions in rats. Arzneium-Forsch/Drug research. 1994;44(1)5:620-626.

Hano J, Bogajski J, Danek L, Wantuch C. The effect of neuroleptic development of gastric ulcers in rats exposed to restraint cold stress. Journal of Pharmacology. 1976;32(54):23-25.

Prino G, Paglialunga S, Nardi G, Lietti A. Inhibition of experimentally induced gastric ulcers in the rat by a new sulfated glycopeptide European Journal of Pharmacology. 1971;15:119-126.

Opoka D, Adamek D, Plonka M, Reczynski W, Bas B, Drozdowicz D, Jagielski P, Sliwoski Z, Adamski P, Brzozowski T. Importance of Luminal and Mucosal Zinc in the mechanism of experimental gastric ulcer. Journal of Physiology and Pharmacology. 2010;5(61):581-591.

Kirchhoff P, Thenral S, Shafik S, Andrew D, Tobias B, Christain G, Carsten TV, Christoph B, Daniel O, John PG. Zinc Salts Provide a Novel, Prolonged and Rapid Inhibition of Gastric Acid Secretion. American Journal of Gastroenterology. 2010;327(106):62–70.